Tags

Type your tag names separated by a space and hit enter

One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer.

Abstract

Accumulating evidence from epidemiologic studies suggests that risk of breast cancer is reduced in relation to increased consumption of folate and related B vitamins. We investigated independent and joint effects of B vitamin intake as well as two polymorphisms of a key one-carbon metabolizing gene [i.e., methylenetetrahydrofolate reductase (MTHFR) 677C>T and 1298A>C] on breast cancer risk. The study uses the resources of a population-based case-control study, which includes 1,481 cases and 1,518 controls. Significant inverse associations between B vitamin intake and breast cancer risk were observed among non-supplement users. The greatest reduction in breast cancer risk was observed among non-supplement users in the highest quintile of dietary folate intake [odds ratio (OR), 0.61; 95% confidence interval (95% CI), 0.41-0.93] as compared with non-supplement users in the lowest quintile of dietary folate intake (high-risk individuals). The MTHFR 677T variant allele was associated with increased risk of breast cancer (P, trend = 0.03) with a multivariate-adjusted OR of 1.37 (95% CI, 1.06-1.78) for the 677TT genotype. The 1298C variant allele was inversely associated with breast cancer risk (P, trend = 0.03), and was likely due to the linkage of this allele to the low-risk allele of 677C. The MTHFR-breast cancer associations were more prominent among women who did not use multivitamin supplements. Compared with 677CC individuals with high folate intake, elevation of breast cancer risk was most pronounced among 677TT women who consumed the lowest levels of dietary folate (OR, 1.83; 95% CI, 1.13-2.96) or total folate intake (OR, 1.71; 95% CI, 1.08-2.71). From a public heath perspective, it is important to identify risk factors, such as low B vitamin consumption, that may guide an effective prevention strategy against the disease.

Links

  • FREE Publisher Full Text
  • Authors+Show Affiliations

    ,

    Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York, USA. jia.chen@mssm.edu

    , , , , , , , , ,

    Source

    Cancer research 65:4 2005 Feb 15 pg 1606-14

    MeSH

    Aged
    Breast Neoplasms
    Case-Control Studies
    Diet
    Dietary Supplements
    Female
    Folic Acid
    Genetic Predisposition to Disease
    Humans
    Methylenetetrahydrofolate Reductase (NADPH2)
    Middle Aged
    New York
    Risk Factors
    Vitamin B Complex

    Pub Type(s)

    Journal Article
    Research Support, U.S. Gov't, Non-P.H.S.
    Research Support, U.S. Gov't, P.H.S.

    Language

    eng

    PubMed ID

    15735051

    Citation

    Chen, Jia, et al. "One-carbon Metabolism, MTHFR Polymorphisms, and Risk of Breast Cancer." Cancer Research, vol. 65, no. 4, 2005, pp. 1606-14.
    Chen J, Gammon MD, Chan W, et al. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res. 2005;65(4):1606-14.
    Chen, J., Gammon, M. D., Chan, W., Palomeque, C., Wetmur, J. G., Kabat, G. C., ... Santella, R. M. (2005). One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Research, 65(4), pp. 1606-14.
    Chen J, et al. One-carbon Metabolism, MTHFR Polymorphisms, and Risk of Breast Cancer. Cancer Res. 2005 Feb 15;65(4):1606-14. PubMed PMID: 15735051.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. AU - Chen,Jia, AU - Gammon,Marilie D, AU - Chan,Wendy, AU - Palomeque,Caroline, AU - Wetmur,James G, AU - Kabat,Geoffrey C, AU - Teitelbaum,Susan L, AU - Britton,Julie A, AU - Terry,Mary Beth, AU - Neugut,Alfred I, AU - Santella,Regina M, PY - 2005/3/1/pubmed PY - 2005/4/5/medline PY - 2005/3/1/entrez SP - 1606 EP - 14 JF - Cancer research JO - Cancer Res. VL - 65 IS - 4 N2 - Accumulating evidence from epidemiologic studies suggests that risk of breast cancer is reduced in relation to increased consumption of folate and related B vitamins. We investigated independent and joint effects of B vitamin intake as well as two polymorphisms of a key one-carbon metabolizing gene [i.e., methylenetetrahydrofolate reductase (MTHFR) 677C>T and 1298A>C] on breast cancer risk. The study uses the resources of a population-based case-control study, which includes 1,481 cases and 1,518 controls. Significant inverse associations between B vitamin intake and breast cancer risk were observed among non-supplement users. The greatest reduction in breast cancer risk was observed among non-supplement users in the highest quintile of dietary folate intake [odds ratio (OR), 0.61; 95% confidence interval (95% CI), 0.41-0.93] as compared with non-supplement users in the lowest quintile of dietary folate intake (high-risk individuals). The MTHFR 677T variant allele was associated with increased risk of breast cancer (P, trend = 0.03) with a multivariate-adjusted OR of 1.37 (95% CI, 1.06-1.78) for the 677TT genotype. The 1298C variant allele was inversely associated with breast cancer risk (P, trend = 0.03), and was likely due to the linkage of this allele to the low-risk allele of 677C. The MTHFR-breast cancer associations were more prominent among women who did not use multivitamin supplements. Compared with 677CC individuals with high folate intake, elevation of breast cancer risk was most pronounced among 677TT women who consumed the lowest levels of dietary folate (OR, 1.83; 95% CI, 1.13-2.96) or total folate intake (OR, 1.71; 95% CI, 1.08-2.71). From a public heath perspective, it is important to identify risk factors, such as low B vitamin consumption, that may guide an effective prevention strategy against the disease. SN - 0008-5472 UR - https://www.unboundmedicine.com/medline/citation/15735051/One_carbon_metabolism_MTHFR_polymorphisms_and_risk_of_breast_cancer_ L2 - http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=15735051 DB - PRIME DP - Unbound Medicine ER -